PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,443,000 | – | 380,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,585,500 | $3,710,000 | 1.36% |
| SMH CAPITAL ADVISORS INC | 83,369 | $195,000 | 0.32% |
| West Family Investments, Inc. | 338,141 | $791,000 | 0.20% |
| Matarin Capital Management, LLC | 927,289 | $2,169,856,000 | 0.16% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $33,000 | 0.12% |
| Alambic Investment Management, L.P. | 163,200 | $382,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,760,376 | $4,119,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,677,647 | $13,286,000 | 0.08% |
| Zebra Capital Management LLC | 67,892 | $159,000 | 0.07% |
| Fortis Advisors, LLC | 45,602 | $107,000 | 0.06% |